Introduced

Passed House

Passed Senate

Became law

Adjourned sine die. The bill was pending when the session ended, so it did not pass.

Last action · January 15, 2026

To Health Services (H)

Introduced January 8, 2026

House

Adjourned Sine Die

2026 Regular Session

HB263

AN ACT relating to undesignated glucagon.

Create new sections of KRS Chapter 217 to define terms; permit health care practitioners to prescribe and dispense undesignated glucagon in the name of a school; permit authorized entities to receive, possess, and administer undesignated glucagon to a student during diabetic medical emergencies; permit schools to stock undesignated glucagon; provide for immunity from civil liability for any personal injury resulting from good-faith actions to use undesignated glucagon to treat diabetic medical emergencies; require the Cabinet for Health and Family Services to consult the American Diabetes Association when promulgating administrative regulations related to the administration of undesignated glucagon in schools.

Administrative Regulations and Proceedings Children and Minors Civil Actions Diseases Drugs and Medicines Education, Elementary and Secondary Health Care Professionals Nurses Pharmacists Physicians State Agencies Teachers

Read the full text Kentucky Legislature LegiScan

AI-generated. Always verify with primary sources

Plain-language summary

Beta

This bill would allow Kentucky schools to keep a supply of glucagon on hand for emergencies, even if it is not prescribed to a specific student. School staff who are authorized under the bill could use it to treat a student experiencing a severe diabetic emergency, and those acting in good faith would be protected from civil liability. Who it may affect: students with diabetes, school staff and administrators, parents of children with diabetes.

Open official bill text (PDF)·Report a problem with the summary